PG vs TMO: Which Is the Better Buy?
Side-by-side comparison of The Procter & Gamble Company and Thermo Fisher Scientific Inc. β fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-18.
The Procter & Gamble Company Β· Consumer Defensive
$147.04
+14.4% upside to fair value
Med Conviction
Grade B+
High Quality
VS
Thermo Fisher Scientific Inc. Β· Healthcare
$658.32
+31.1% upside to fair value
Med Conviction
Grade B
High Quality
QuantHub Verdict
TMO has more upside to fair value
(+31.1%).
These are model outputs β not personalized investment advice.
See all research β
Valuation & Fundamentals
| Metric |
PG |
TMO |
| Current Price |
$147.04 |
$658.32 |
| Fair Value Estimate |
$168.19 |
$863.34 |
| Upside to Fair Value |
+14.4%
|
+31.1%
|
| Market Cap |
$349.5B |
$244.7B |
| Forward P/E |
β
|
β
|
| EV / EBITDA |
17.6x
|
25.9x
|
| Price / Sales |
4.0x
|
5.3x
|
| Price / FCF |
22.4x
|
33.4x
|
| Revenue Growth YoY |
+1.5%
|
+10.5%
|
| Gross Margin |
50.2%
|
40.4%
|
| Operating Margin |
22.7%
|
17.7%
|
| Return on Equity |
29.8%
|
13.4%
|
| Dividend Yield |
2.92% |
0.28% |
| FCF Yield |
4.47%
|
3.0%
|
| Analyst Consensus |
Buy
|
Strong Buy
|
Investment Thesis
Procter & Gamble is a global consumer-staples leader selling daily-use products across beauty, grooming, health care, fabric and home care, and baby, feminine and family care in about 180 countries. Business quality is high because its brands, consumer insight, R&D, marketing scale and global distribution underpin leading category positions, including over 60% in blades and razors and over 35% inβ¦
Thermo Fisher Scientific is a global life-sciences and laboratory-services platform spanning Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services, with recognized brands including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Patheon, and PPD, serving pharmaceutical, biotech, clinical, academic, and governmeβ¦
Accumulation Zones
| Metric |
PG |
TMO |
| Zone Low |
$126.14 |
$647.50 |
| Zone High |
$142.96 |
$733.84 |
| In Buy Zone? |
No
|
Yes
|